May 2020 PMID 31975514

Withania somnifera (Indian ginseng) in diabetes mellitus: A systematic review and meta-analysis of scientific evidence from experimental research to clinical application.

Sharanbasappa Durg, Sachin Bavage, Shivakumar B Shivaram

Full text PDF Download social card

Mentions

Peak: 5 in Feb 2024

across 5 sources since Feb 2024

Extended reach

165,640

potential audience

Total likes

3,924

Video views

165,537

Mentions per month

Feb 2024 – Aug 2025

Where it's discussed

News60 articles
YouTube5 videos
Blogs4 articles
Facebook2 posts
X / Twitter1 posts

AI synopsis

What people are saying

The social discussions highlight that participants recognize the potential of Withania somnifera for health benefits, referencing terms like 'stress relief' and 'natural remedies,' which reflects an interest in alternative medicine. The tone varies between cautious optimism and general curiosity, demonstrating moderate engagement and acknowledgment of possible impact, but without outright endorsement of the clinical findings.

AgreementModerate agreement

Most discussions support the idea that Withania somnifera has potential benefits for diabetes management, aligning with the article's cautious optimism about its effects.

InterestModerate interest

Commenters express some curiosity about the herbal treatment, mentioning benefits like stress relief and overall health, showing moderate interest.

EngagementNeutral engagement

While some posts reference specific health benefits and scientific studies, others simply mention the plant's general uses, indicating a moderate level of engagement.

ImpactModerate impact

These discussions suggest an awareness that the research could influence alternative treatment options, but they stop short of claiming immediate clinical application.

Abstract in brief

This review and meta-analysis suggest that Withania somnifera (Indian ginseng) may help manage diabetes by reducing blood sugar levels, improving lipid profiles, and addressing oxidative stress, with no safety issues reported.
The current clinical evidence is limited and not strong enough to recommend W. somnifera as a standard treatment for diabetes, highlighting the need for more well-designed, large-scale studies.
Future research should focus on understanding how W. somnifera works at the molecular level and identify its active components to better establish its role in diabetes management.]

Read the full abstract